Add this blogServices
We provide an integrated approach to the regulatory and transactional issues that arise in the context of lending and private equity sponsor transactions. In particular, we bring a deep understanding of the embedded regulatory matters to provide a thorough due diligence analysis of a target company’s operations identifying potential regulatory and legal risks and cash flow disruptions. Our analysis includes reviewing compliance with federal Medicare and Medicaid laws and regulations and state law correlates, and providing advice regarding the potential impact on the future value of the business model. In circumstances where areas of concern arise, we help our clients correct issues and suggest alternative deal structures as appropriate, enabling the deal to go forward while avoiding potential cash flow disruption or prolonged legal actions post closing.
Amber Walsh is a partner with McGuireWoods LLP focusing on healthcare transactional work and regulatory matters. Her experience includes representation
Kristian Werling is a partner with McGuireWoods LLP concentrating in healthcare transactional work and regulatory matters for all participants in
As a partner with the firm, Geoff has a wide scope of expertise spanning mergers and acquisitions, senior and